In addition, biological outcomes (such as alanine aminotransferase [ALT], aspartate aminotransferase [AST], hemoglobin A1c [HbA1c], fasting plasma glucose [FPG], homeostasis model assessment of insulin resistance [HOMA-IR], total cholesterol [T-Chol], low-density lipoprotein-cholesterol [LDL-C], and triglycerides [TG]) and anthropometric outcomes (such as body mass index [BMI] and waist circumference [WC]) were analyzed for further comparison
Additionally, more than 60% of Wegovy-treated participants in this trial achieved at least 10% weight loss, compared to 17% of participants in the placebo group
New GLP-1 Drugs Achieve Record Weight Loss Results - Up to 22% Body Weight Reduction To view or add a comment, sign in Are GLP-1 Weight Loss Drugs Really Causing Muscle Loss, or Are We Simply Asking the Wrong Question
But BPC-157 is not approved to treat any health conditions
How Does MOTS-c Compare to Other Metabolic Peptides
[2] Contraindications Hypersensitivity Reactions Sermorelin is contraindicated in patients with a known hypersensitivity to sermorelin acetate or any excipients in the formulation
